BRIEF published on 11/20/2024 at 18:05, 19 hours 10 minutes ago Route1 Reports Approval of Key Proposals at 2024 Annual Meeting Board Of Directors Financial Results Auditor Appointment Shareholder Proposals Route1 2024 Meeting
PRESS RELEASE published on 11/20/2024 at 18:00, 19 hours 15 minutes ago Route1 Announces 2024 Annual General and Special Meeting Results Route1 Inc. announces approval of shareholder proposals at annual meeting in Toronto. Financial results for Q3 and YTD 2024 to be released on November 26, 2024 Financial Results Toronto Annual Meeting Route1 Inc. Shareholder Proposals
BRIEF published on 08/20/2024 at 18:47, 3 months ago Route1 Announces Q2 2024 Financial Results Financial Results Revenue Decline Net Loss PocketVault Order ALPR Team
PRESS RELEASE published on 08/20/2024 at 18:42, 3 months ago Route1 Announces Q2 2024 Financial Results Route1 Inc. reports Q2 2024 financial results, focusing on revenue, operating profit, and increased PocketVault sales. Company aims to improve Q3 performance and talent acquisition Financial Results Talent Acquisition Q2 2024 Route1 Inc. PocketVault Sales
BRIEF published on 05/15/2024 at 22:05, 6 months 5 days ago Route1 Inc. Reveals Q1 2024 Financial Outcomes Adjusted EBITDA Strategic Adjustments Route1 Financial Results Quarterly Revenue Decline ALPR Contracts Growth
PRESS RELEASE published on 05/15/2024 at 22:00, 6 months 5 days ago Route1 Announces Q1 2024 Financial Results Route1 Inc. (TSXV:ROI) reports Q1 financial results for 2024, with revenue at $4,032, net loss of $(149) thousand, and adjusted EBITDA at $134 thousand. Details on revenue breakdown and operational insights provided Financial Results Q1 2024 Route1 Inc. Revenue Breakdown Operational Insights
BRIEF published on 05/13/2024 at 15:05, 6 months 7 days ago Route1 Inc. Sets Date for Q1 2024 Financial Results Announcement Financial Results Engineering Q1 2024 Professional Services Route1 Inc
PRESS RELEASE published on 05/13/2024 at 15:00, 6 months 7 days ago Route1 Announces Details of the Timing of the Release of its First Quarter 2024 Results Route1 Inc. to report financial results for the three-month period ended March 31, 2024 on May 15, 2024. The advanced North American provider offers turn-key engineering and professional services Financial Results Professional Services Route1 Inc. North American Provider Turn-key Engineering
BRIEF published on 04/25/2024 at 05:05, 6 months 26 days ago Route1 Inc. Reports Decline in Annual Financial Performance for 2023 Financial Results Revenue Decline Fiscal Year 2023 Net Loss Route1 Inc.
PRESS RELEASE published on 04/25/2024 at 05:00, 6 months 26 days ago Route1 Announces Q4 and Fiscal Year 2023 Financial Results Route1 Inc. (TSXV:ROI) reported financial results for FY and Q4 2023. Revenue, operating profit, and net income data provided Financial Results Revenue Q4 2023 FY 2023 Route1 Inc.
Published on 11/21/2024 at 13:00, 15 minutes ago Aclara Secures Funding from Corfo's Innovation High-Tech Program for Artificial Intelligence Project
Published on 11/21/2024 at 13:00, 15 minutes ago Telomir Pharmaceuticals Confirms Age Reversal, Increased Longevity and Improved Healthspan in Groundbreaking Preclinical Study with Telomir-1
Published on 11/21/2024 at 13:00, 15 minutes ago Toggle3D.ai Rebrands as FOTOgpt.ai to Usher in a New Age of AI-Powered Photography
Published on 11/21/2024 at 13:00, 15 minutes ago Nextech3D.ai Spin-Out Rebrands as FOTOgpt.ai to Usher in a New Era of AI-Powered Photography
Published on 11/21/2024 at 13:00, 15 minutes ago Clean Air Metals Announces Positive Results from Innovative Seismic Survey at the Escape Deposit Down-Plunge Extension
Published on 11/21/2024 at 12:35, 39 minutes ago audius with successful third quarter 2024 - total revenue grows by +9.2% and EBITDA by +14.6
Published on 11/21/2024 at 12:15, 1 hour ago Hardman & Co Investor Forum Research on Shield Therapeutics (STX): Proactive cash management to cashflow-breakeven
Published on 11/21/2024 at 11:30, 1 hour 45 minutes ago APONTIS PHARMA AG: Condition of Minimum Acceptance in Zentiva’s Voluntary Public Purchase Offer Waived
Published on 11/21/2024 at 06:58, 6 hours 17 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 17 hours 55 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 19 hours 30 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 19 hours 30 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 5 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
